Latest Amines Stories
New information from d’Oliveira & Associates helps you evaluate the risks of taking antidepressants during pregnancy. (PRWEB) May 23, 2013 During pregnancy both the health of the mother and the growing fetus are affected by medical treatments, especially medication. In July 2006, a study published by the New England Journal of Medicine prompted the FDA to warn about a potential link between certain antidepressant drugs and serious birth defects such as persistent pulmonary...
- Pricing Negotiations to Begin in June - SEATTLE, May 20, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported that Germany's Federal Joint Committee (G-BA) has issued its final benefit assessment report for PIXUVRI® (pixantrone), which is indicated as a monotherapy for the treatment of adult patients with aggressive B-cell non-Hodgkin lymphoma (NHL) who have failed two or three prior lines of therapy. The G-BA reported that additional benefit...
Results Presented at 166th Annual American Psychiatric Association Meeting SAN FRANCISCO, May 18, 2013 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and H. Lundbeck A/S (Lundbeck) today announced that the companies will be presenting new data from four studies that evaluated effectiveness in treating the overall symptoms of depression in patients taking vortioxetine, an investigational agent under review with the U.S. Food and Drug Administration (FDA) for the...
Lawyers will update judge about consolidated federal litigation involving hundreds of lawsuits claiming SSRI anti-depressant use allegedly caused birth defects. Free consultations about legal options are now available to consumers. San Diego, CA (PRWEB) May 17, 2013 http://www.resource4thepeople.com/defectivedrugs/zoloft.html Resource4thePeople today announced it is providing consumers its latest update about consolidated federal lawsuits* involving allegations that the use of Zoloft or...
Data Showed Reduced Nocturnal Systolic Blood Pressure Elevations and Periodic Limb Movements During Sleep in Restless Legs Syndrome (RLS) Patients ATLANTA, May 17, 2013 /PRNewswire/ -- UCB today announced data from a double-blind, placebo-controlled study that found that Neupro(®) (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations associated with periodic limb movements during sleep (PLMS) and total PLMS in patients with idiopathic...
Methadone addiction issues addressed through Recovery Associates Methadone Drug Treatment Program. Their different treatment tracks support and encourage people to give up addictive substances and create a new life in recovery. Tampa, Florida (PRWEB) May 13, 2013 Methadone has been used to help people caught in the web of drug addiction to stop. Yet, some physicians prescribe methadone to patients who, without proper guidance and supervision, will overuse this medication. The results are...
Chief Scientist Participates in Clinical and Basic Science Data Blitz MORAGA, Calif., May 9, 2013 /PRNewswire/ -- Trigemina, Inc., a biopharmaceutical company focused on the discovery and development of non-narcotic, nasally delivered, analgesic drug products, announced that David C. Yeomans, Ph.D., Chief Scientist and Founder, as well as the Director of Pain Research at Stanford University School of Medicine, gave a presentation at the American Pain Society (APS) 32(nd) Annual...
LONDON, May 7, 2013 /PRNewswire/ -- Founder of the drugs charity, Angelus, Maryon Stewart, described the Home Office as "delinquent" in sponsoring a legal high supplier's e-petition. The Home Office have discretion to reject any e-petition under various conditions but chose to sponsor one by UK Skunkworks. The company in question, UK Skunkworks, is the largest supplier of legal psychoactive drugs in southern Britain with 15 shops. It sells products with known harms such...
April Flowers for redOrbit.com - Your Universe Online A new study from the Ann Arbor Veterans Health Administration (VA) Healthcare System and the University of Michigan reveals the US Food and Drug Administration’s (FDA) warning that high doses of citalopram, also known as Celexa, can cause potentially serious abnormal heart rhythms might be doing more harm than good. The FDA attached a warning to the antidepressant in 2011, based on data linking higher doses of the drug to...
- Conference call scheduled today at 4:30 p.m. Eastern time - SEATTLE, May 2, 2013 /PRNewswire/ -- Cell Therapeutics, Inc. (CTI) (NASDAQ and MTA: CTIC) today reported financial results for the first quarter ended March 31, 2013. "In the first quarter, we generated initial commercial sales of PIXUVRI(®) in countries in the European Union where there is market access pending the completion of the reimbursement process," said James Bianco, M.D., President and CEO of CTI. "Although...
